Rabu, 09 Oktober 2019

Johnson & Johnson Risperdal verdict: Company hit with $8B verdict after drug linked to boy growing breasts - CBS News

A Philadelphia jury has ordered medical company Johnson & Johnson to pay $8 billion dollars in punitive damages in the case of a man who said he developed breasts after taking the company's anti-psychotic drug Risperdal as a child. The case is unrelated to a string of big-money lawsuits the company is facing over its signature baby powder

In the Risperdal case, a jury found that Johnson & Johnson failed to warn 26-year-old Nicholas Murray of the drug's side effects. Murray claimed that taking the Risperdal as a child caused him to develop breasts, an incurable condition known as gynecomastia. Thousands of others have filed lawsuits alleging the same.   

Murray said he was prescribed the medicine at age 9 for symptoms related to autism spectrum disorder, despite the fact that the FDA's approval of the drug in the 1990s was to treat schizophrenia and episodes of bipolar mania in adults.

Attorneys for Murray alleged the company marketed the drug for unapproved, off-label use in children to increase profits, choosing "billions over children."

Johnson & Johnson denied the allegations, and said it's confident the ruling will be overturned. In a statement, the company said it was "precluded from presenting ... key evidence..." The company further claimed that evidence showed how the label for the drug "clearly and appropriately outlined the risks associated with the medicine." 

Murray's attorneys told "CBS This Morning" consumer investigative correspondent Anna Werner that the punitive damages were meant to deter the company from similar conduct in the future. They believe the decision will stand.

© 2019 CBS Interactive Inc. All Rights Reserved.

Let's block ads! (Why?)


https://www.cbsnews.com/news/johnson-johnson-risperdal-company-8-billion-verdict-boy-allegedly-takes-anti-psychotic-develops-breasts/

2019-10-09 11:40:00Z
52780404671673

China's toughness amid Trump impeachment talk misplaced - Fox Business

As the Democrats ratchet up impeachment talk, they may be giving the Chinese false hope that high-level trade negotiations with the U.S., which resume Thursday, will get easier.

Continue Reading Below

“They are looking very closely at what’s going on in the U.S., and this impeachment inquiry is effecting, I think, their negotiating position, making them much tougher than they ordinarily would be,” Gordon Chang, the author of “Coming Collapse of China” told Fox News’ “Tucker Carlson Tonight.” “They have signaled in the last couple days they’re just not going to talk about the core issues that U.S. negotiators demand that we discuss,” Chang added.

However, underestimating the U.S. and Trump may be a miscalculated move, Myron Brilliant, executive vice president and head of International Affairs at the U.S. Chamber of Commerce, tells FOX Business.

“With rising tensions, it would be a huge mistake for China to play the waiting game on trade talks. Concerns over China’s trade practices are not a partisan issue. There is strong bipartisan consensus in our country that China needs to take concrete and measurable actions to address a range of unfair trade practices.  China should be doubling down during this critical window to make constructive offers that will lead to a high-standard, enforceable agreement" he said.

In the last 24 hours, the White House has upped the pressure on the Chinese.

On Tuesday, the U.S. State Department imposed visa restrictions on Chinese officials for human rights repression in Xinjiang. This followed a move Monday when the U.S. added 28 names to its blacklist, including a government entity. Inclusion on the list, which designates entities believed to act in ways contrary to U.S. foreign policy or national security interests, restricts access to American goods.

Additionally, top White House economic advisor Larry Kudlow told FOX Business the U.S. was reviewing Chinese companies listed on U.S. exchanges amid alleged investor complaints. And the White House is also considering restricting government pension fund investments in China.

“The idea that we’re going back to a peaceful, harmonious, happy U.S.-China relationship, I think that’s over,” Michael Pillsbury, American director of the Center on Chinese Strategy, told FOX Business’ “Mornings with Maria.” “It’s clearly going to be a kind of certainty that there will be U.S.-China friction.”

GET FOX BUSINESS ON THE GO BY CLICKING HERE

On Tuesday, it was announced that Chinese Vice Premier Liu He, who is leading the delegation, has not been designated as special envoy, meaning he cannot make any decisions and must report to President Xi Jinping, shelving any hopes for a deal to be reached this week.

Meanwhile, the IMF warned the U.S.-China trade war, if it continues, will produce no winners.

The 15-month long trade war between the U.S. and China could cost an increasingly fragile global economy about $700 billion, or 0.8 percent of GDP, by 2020, Kristalina Georgieva, the new chief of the International Monetary Fund, said in her first speech on Tuesday.

"It's a little bit like you know a sumo match, they're sort of both in the ring grappling," Center for Strategic and International Studies Scholl Chair and Senior Adviser Bill Reinsch told FOX Business.

CLICK HERE TO READ MORE ON FOX BUSINESS

"We've gone beyond stomping on the earth and glaring in each other's face, but they can't agree but they can't leave. If Trump leaves it's a failure on a signature issue. If they leave it lets him off the hook. He can blame them for everything, exposes them to further retaliation which they don't want. So everybody keeps talking."

Let's block ads! (Why?)


https://www.foxbusiness.com/markets/dems-impeachment-inquiry-china-false-hope-trade-talks

2019-10-09 10:31:13Z
52780404540953

Johnson & Johnson ordered to pay man $8 BILLION over drug causing him to grow breasts - RT

A Philadelphia jury on Tuesday said that Johnson & Johnson (J&J) must pay $8 billion in punitive damages to a man over his claims that a drug manufactured by the US firm caused him to grow breasts.

The verdict in favor of Nicholas Murray, 26, came first in one of thousands of Risperdal cases pending in Pennsylvania.

Murray, like other male plaintiffs in the mass tort litigation over Risperdal, alleges that he developed breasts after being prescribed the medicine and taking it from 2003 to 2008. A psychologist prescribed the drug after diagnosing him with autism spectrum disorder. In late 1993, the drug was approved by the Food and Drug Administration for treating schizophrenia and episodes of bipolar mania in adults.

Also on rt.com Johnson & Johnson gets $572mn slap on wrist for causing opioid crisis in Oklahoma

Four years ago, a jury awarded Murray $1.75 million after finding that J&J was negligent in failing to warn consumers of the risks. A state appeals court upheld the verdict last year, but reduced it to $680,000.

“This jury, as have other juries in other litigations, once again imposed punitive damages on a corporation that valued profits over safety and profits over patients,” Murray’s lawyers, Tom Kline and Jason Itkin, said. “Johnson & Johnson and [subsidiary] Janssen chose billions over children,” they said.

J&J said the award was “grossly disproportionate with the initial compensatory award in this case, and the company is confident it will be overturned.” It added that the jury in the case had not been allowed to hear evidence of Risperdal’s benefits.

Plaintiffs claim that Johnson & Johnson failed to warn of the risk of gynecomastia (the development of enlarged breasts in males) associated with Risperdal, which they say J&J marketed for unapproved use with children.

Also on rt.com Companies people love to hate: World’s most despised corporations

Plaintiffs in the mass tort litigation had been barred from seeking punitive damages since 2014, when a state court judge ruled that the law of New Jersey (which prohibits punitive damages and is J&J’s home state) should be applied globally to the cases.

In 2018, a Pennsylvania Superior Court ruling cleared the way for punitive damages awards, holding that the law of each plaintiff’s state should instead apply.

For more stories on economy & finance visit RT's business section

Let's block ads! (Why?)


https://www.rt.com/business/470502-billions-payment-male-breast-growth/

2019-10-09 08:24:00Z
52780404671673

Dow futures jump 200 points on a report China is open to a partial US trade deal - CNBC

U.S. stock index futures jumped Wednesday morning on a Bloomberg report that said China is open to agreeing to a partial trade deal with the U.S.

Around 5:40 a.m. ET, Dow futures indicated a positive open of about 200 points. Futures on the S&P and Nasdaq were both higher as well.

Market focus is largely attuned to global trade developments, with high-level negotiators from the U.S. and China poised to meet for a fresh round of talks in Washington, D.C., on Thursday. Citing an official with direct knowledge of the talks, Bloomberg reported that China is prepared to accept a partial trade deal as long as no more tariffs are imposed by President Donald Trump. (Read the complete report here.)

President Trump has said tariffs on Chinese imports will increase on October 15 if no progress is made in bilateral trade negotiations.

The world's two largest economies have imposed tariffs on billions of dollars' worth of one another's goods since the start of 2018, battering financial markets and souring business and consumer sentiment.

The long-running dispute has slowly expanded beyond trade policy, exacerbating fears about further damage to a fragile global economy.

To be sure, U.S. visa restrictions on Chinese officials and the addition of more Chinese companies to a U.S. trade blacklist this week has dampened already slim hopes of a trade truce.

On the data front, weekly mortgage application numbers are expected out at 7 a.m. ET, and wholesale trade figures for August and Job Openings and Labor Turnover Survey (JOLTS) data for August will both be released at around 10 a.m. ET.

Let's block ads! (Why?)


https://www.cnbc.com/2019/10/09/stock-market-wall-street-looks-ahead-to-us-china-trade-talks.html

2019-10-09 06:34:39Z
52780404540953

Johnson & Johnson ordered to pay man $8bn over breast growth - BBC News

US drug firm Johnson & Johnson has been told to pay $8bn (£6.6bn) in punitive damages to a man over claims he was not warned that an antipsychotic drug could lead to breast growth.

A Philadelphia jury made the award to Nicholas Murray, 26, whose case was one of thousands pending in the state.

His lawyers argued that J&J subsidiary Janssen put "profits over patients" in marketing the drug Risperdal.

J&J will appeal the ruling, which it said was "grossly disproportionate".

The US giant is also facing court challenges over vaginal mesh implants and baby powder allegedly tainted with asbestos. That's in addition to an ongoing legal battle over its role in the US opioid addiction crisis.

Earlier this year, the company was ordered to pay $572m for its part in fuelling Oklahoma's opioid addiction crisis. It recently agreed to a $20.4m settlement with two counties in the US state of Ohio over claims it fuelled the crisis there.

The company's mounting legal bills have caused concern among some investors, but its earnings have remained strong.

In Risperdal lawsuit said Mr Murray developed breasts after his doctors began prescribing him the drug in 2003. A psychologist prescribed the drug after diagnosing him with autism spectrum disorder.

Risperdal is approved for the treatment of schizophrenia and bipolar disorder, but doctors can legally prescribe medicine for any condition they see fit.

The company said it is confident the ruling will be overturned, and said the court prevented their legal team from presenting "key evidence" on the drug's labelling.

J&J is facing a series of complaints in state courts for failing to properly warn of Risperdal's side effects, including in Pennsylvania, California and Missouri.

A jury in 2015 awarded Mr Murray $1.75m after finding the company was negligent in failing to warn consumers of the risks.

A state appeals court upheld the verdict in last year, but reduced it to $680,000.

Let's block ads! (Why?)


https://www.bbc.com/news/business-49982237

2019-10-09 06:33:31Z
52780404671673

US futures point to slightly higher open - CNBC

U.S. stock index futures were slightly higher Wednesday morning.

At around 02:20 a.m. ET, Dow futures rose 43 points, indicating a positive open of more than 61 points. Futures on the S&P and Nasdaq were both marginally higher.

Market focus is largely attuned to global trade developments, with high-level negotiators from the U.S. and China poised to meet for a fresh round of talks in Washington, D.C., on Thursday.

The long-running dispute has slowly expanded beyond trade policy, exacerbating fears about further damage to a fragile global economy.

To be sure, U.S. visa restrictions on Chinese officials and the addition of more Chinese companies to a U.S. trade blacklist this week has dampened already slim hopes of a trade truce.

President Donald Trump has said tariffs on Chinese imports will increase on October 15 if no progress is made in bilateral trade negotiations.

The world's two largest economies have imposed tariffs on billions of dollars' worth of one another's goods since the start of 2018, battering financial markets and souring business and consumer sentiment.

On the data front, wholesale trade figures for August and Job Openings and Labor Turnover Survey (JOLTS) data for August will both be released at around 10:00 a.m. ET.

Let's block ads! (Why?)


https://www.cnbc.com/2019/10/09/stock-market-wall-street-looks-ahead-to-us-china-trade-talks.html

2019-10-09 06:27:43Z
52780404540953

Selasa, 08 Oktober 2019

Dick's has destroyed $5 million worth of weapons, its CEO says - CNN

After finding out that Dick's had sold the Parkland shooter a shotgun, CEO Edward Stack decided last year the company would no longer sell firearm to anyone under 21. Dick's announced it would destroy its inventory of weapons, rather than allow them to be sold by another retailer.
Since then, about $5 million of the chain's gun inventory has been turned into scrap metal, Stack said in an interview with CBS.
"All this about, you know, how we were anti-Second Amendment, you know, 'we don't believe in the Constitution,' and none of that could be further from the truth," he said in the interview. "We just didn't want to sell the assault-style weapons that could inflict that kind of damage."

The shooting

Stack is a hunter and gun owner who believes strongly in the Second Amendment. The company, which his father started as a fish-and-tackle shop in 1948, has sold guns since long before Stack started working there in 1977.
But the mass shooting at Marjory Stoneman Douglas High School in Florida, on February 14, 2018, changed that. Seventeen people were killed in the attack.
Though the gun sold to the shooter was not the AR-15-style rifle used in the shooting, Stack said he couldn't stand being part of the narrative of mass shootings.
"We had a pit in our stomach," he told CNN soon after the shooting. "We did everything by the book that we were supposed to do, from a legal standpoint, we followed everything we were supposed to do. And somehow this kid was still able to buy a gun from us."

The decision

Stack told CBS the controversial decision cost his company about a quarter of a billion dollars in revenue.
Dick's is not the only national chain to be grappling with gun sales.
Walmart announced in September that it would reduce its gun and ammunition sales significantly, also requesting that customers no longer open carry guns into their stores, even in states that allow open carry.

Let's block ads! (Why?)


https://www.cnn.com/2019/10/08/business/dicks-sporting-goods-destroys-weapons-trnd/index.html

2019-10-08 12:56:00Z
52780404292977